For example, METTL16 has been shown to inhibit ferroptosis in HCC cells, promoting tumor progression, and its high expression correlates with poor prognosis in HCC patients (Wang J. et al., 2024). This evidence concerns the gene METTL16 and hepatocellular carcinoma.